Sort
10,829 grants matching “car t”
VLA-4âtargeted 67Cu-LLP2A preconditioning enhances efficacy of T-cell-based adoptive immunotherapy
$611,562Ravi Bhasker Patel · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics with Diabetes
$611,361Athena Philis-Tsimikas · Scripps Health · R01 · FY2016 · DK
MAPS: Mobile Assessment for the Prediction of Suicide
$611,178Nicholas B Allen · University Of Oregon · U01 · FY2022 · MH
Virtual Reality by Mobile Phone: Improving Child Pedestrian Safety
$611,177David C Schwebel · University Of Alabama At Birmingham · R01 · FY2016 · HD
Montana Cancer Consortium NCORP
$611,042Benjamin T. Marchello · Montana Cancer Consortium · UG1 · FY2016 · CA
Efficacy trial for a smartphone game to prevent HIV among young Africans
$610,754Samantha K Winskell · Emory University · R01 · FY2022 · MH
Study of CAR T cells and mechanisms of resistance in pediatric brain tumors
$610,644Anandani Nellan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Mechanoimmunological interactions between TCR-T cells and tumor fibrotic microenvironment
$610,531Ruogang Zhao · State University Of New York At Buffalo · R01 · FY2023 · CA
Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy
$610,197Bianca Denise Santomasso · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Programming multi-pronged immune response to glioblastoma with IL-13Ra2/TGF-b CAR-T cell therapy.
$610,097Yvonne Yu-Hsuan Chen · University Of California Los Angeles · R01 · FY2025 · NS
ASSESSMENT OF ENDOGENOUS AND CAR T-CELL IMMUNITY FOLLOWING ANTI-PD-1 AGENT AS A TRANSITION STEP TO PHASE 2 COMBINATION IMMUNOTHERAPY
$609,922Sloan-Kettering Institute For Cancer Research · · FY2019 · Department of the Army
Delivering Psychosocial Treatment to Substance Abusers via Mobile Technologies
$609,715Michelle C Acosta · National Development And Research Institutes, Inc. · R01 · FY2014 · DA
Large-scale Data Scientific Assessment of Unhealthy Alcohol Consumption Among Front-Line Restaurant Workers
$609,616Hansen Andrew Schwartz · State University New York Stony Brook · R01 · FY2022 · AA
Trispecific CAR-T cells targeting CD19, CD20 and CD22 to treat B-cell malignancies
$609,273Sumithira Vasu · Ohio State University · R01 · FY2023 · CA
Trispecific CAR-T cells targeting CD19, CD20 and CD22 to treat B-cell malignancies
$609,273Sumithira Vasu · Ohio State University · R01 · FY2025 · CA
Career: Correct-by-Learning Methods for Reliable Autonomy
$609,076Sicun Gao · University Of California-San Diego · · FY2021 · CSE
PERCEPTUAL CORRELATES OF REAR-END COLLISIONS AND AGE
$608,973Rsk Assessments, Inc. · R44 · FY2000 · AG
Developing and Strengthening Cannabis Warnings
$608,472Leah Marie Ranney · Univ Of North Carolina Chapel Hill · R01 · FY2024 · DA
Prevalence and Clinical Correlates of Thirdhand Smoke Exposure in a Pediatric Patient Population
$608,440E. Melinda Melinda Mahabee-Gittens · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · ES
CD4+ T cells and neoantigens in melanoma immunotherapy.
$608,260Rongfu Wang · University Of Southern California · R01 · FY2024 · CA
Multi-Level Intervention Addressing Intersectional Stigma to Improve HIV Testing in MSM
$608,171Laron E Nelson · Yale University · R01 · FY2019 · NR
Core B (Animal Core)
$608,058Dale Adam Lauver · Michigan State University · P01 · FY2023 · HL
Gamma delta T cell based melanoma therapies
$608,024Xiaowei Xu · University Of Pennsylvania · R01 · FY2024 · CA
S&AS: FND: A Stochastic Ethical Decision-Making Framework for Long-Term Autonomy
$608,001Katia P Sycara · Carnegie Mellon University · · FY2017 · CSE
HCC: Small: Leadership Emergence for Synchronous Human-Autonomy Teaming
$608,000Nathan Lau · Virginia Polytechnic Institute And State University · · FY2023 · CSE